Aims There is evidence that oral dipyridamole, a nucleoside uptake blocker that increases myocardial adenosine levels, lessens myocardial ischaemia by inducing coronary collateral growth in animal models of ischaemic heart disease. However, whether dipyridamole can exert a similar effect in humans with coronary artery disease is controversial.
Introduction
There is evidence that factors increasing coronary blood flow velocity and wall stress, such as exercise or vasodilatory medications, improve coronary collateral flow and lessen ischaemic dysfunction of collateraldependent myocardium in animal models of coronary artery disease [1, 2] . The mechanisms underlying these effects have not been fully elucidated. A plausible explanation may be that, in the presence of a coronary stenosis, an increase in oxygen demand relative to supply induces myocardial hypoxia, which can promote coronary collateral development [3] . An alternative hypothesis suggests that repeated mechanical stress of coronary vessels induced by exercise or a vasodilator may either stimulate endothelial cells to produce vasoactive susbstances (nitric oxide) or mechanically vasodilate small coronary vessels [4] . A recent report has demonstrated that the increase in collateral-dependent blood flow was greater in dipyridamole-treated than in either diltiazem-treated or placebo-treated pigs [5] . Dipyridamole, an inhibitor of cell nucleoside transport, reduces the uptake of adenosine by cells, and thereby increases the interstitial concentration of adenosine [6] . An increase in adenosine concentration causes coronary vasodilation and increased coronary blood flow [7, 8] . Adenosine also causes endothelial cell proliferation and migration in vitro [9] and promotes angiogenesis [10, 11] . Consistent with this, long-term administration of dipyridamole has been shown to increase myocardial capillary density [12] . More recently, short-term moderate exercise training has been demonstrated to increase myocardial perfusion and contractility of dysfunctional myocardium in humans [13] . We hypothesize that an increase of plasma adenosine (and presumably myocardial) concentration caused by dipyridamole may stimulate coronary collateralization, and that this effect may translate into improvements in myocardial perfusion and contractile function. We also sought to determine whether the combination of dipyridamole and exercise training could exert an additive effect to increase coronary collateral development and myocardial perfusion.
Methods
Thirty male patients with documented coronary artery disease and left ventricular dysfunction were studied. All patients were in sinus rhythm, had had a myocardial infarction more than 6 months before the study, and were asymptomatic for angina in the last 3 months. Clinical characteristics of patients are summarized in Table 1 . Patients with unstable angina, recent acute myocardial infarction, uncontrolled hypertension, haemodynamically significant valvular heart disease and neurologic and/or orthopedic illnesses that limit exercise capacity were excluded. Patients were not actively involved in programmes of cardiac rehabilitation or exercise training. All patients were non-smokers and non-drinkers and abstained from methylxanthinecontaining foods including tea, coffee, cola drinks and chocolate. Aspirin and acetaminophen were withdrawn 2 weeks before enrolment and were not allowed during the study. Other medications were not altered during the study.
Protocol
The protocol was approved by the Ethical Committee of the Lancisi Institute. All patients gave informed written consent. Patients were randomized into three groups matched for anatomical and functional correlates. Ten patients received dipyridamole at a dose of 75 mg t.i.d. for 8 weeks (group A). This dose of dipyridamole is similar to that usually prescribed for clinical purposes and was selected to cause an increase in plasma adenosine concentration [6] . Ten patients (group B) received dipyridamole at the same dose for 8 weeks, and during this time underwent a supervised programme of exercise training. Exercise was performed at the hospital gym on a stationary cycle ergometer for 30 min at 60% of peak oxygen uptake three times per week for 8 weeks. Ten patients had neither dipyridamole nor were exercised for 8 weeks (group C). Patients in group C were advised not to exercise at home, but to continue participating in normal daily mild activity. All patients were regularly visited by a cardiologist in hospital every 3 weeks. Upon entry into the study and after 8 weeks all patients underwent cardiopulmonary exercise testing, low-dose dobutamine stress echocardiography, 201-thallium planar myocardial scintigraphy using a stressredistribution-reinjection protocol, and coronary angiography. Plasma adenosine levels were also measured upon entry into the study and at 8 weeks in all patients. All studies were performed by skilled operators and evaluated by two experienced observers blinded to each others' interpretation. A third observer was asked to resolve differences when agreement was not achieved. A consensus decision was obtained in all cases.
Plasma adenosine measurement
Blood was drawn from an antecubital vein in the morning. Patients were fasted and medications were withheld for 12 h preceeding collection of a blood sample.
Analysis
Plasma from heparinized venous blood was collected and analysed in duplicate for adenosine, as previously described [14] . Briefly, during collection, 2 ml of blood was instantly mixed with an equal volume of a . Immediately after collection, the mixture of blood and stop solution (4 ml) was centrifuged at 4800 g for 2 min. Each supernate was then filtered and 106 pmol of N 6 -methyladenosine was added to 1 ml of filtrate. To purify and concentrate the adenosine in the sample both boronate and C 18 Sep-Pak columns (Waters) were used. A HPLC system (Beckman) was used for analysis. The amount of adenosine in each sample was determined by comparing the observed peak area with that of a standard.
Reproducibility
To assess inter-and intra-individual variability, duplicate plasma samples were collected twice daily for 5 days from five patients (three men, two women, mean age 53 8 years) with coronary artery disease who refrained from methylxanthine-containing foods and medications such as aspirin and xanthines at least 10 days before the test. The first daily sample was drawn after an overnight fast and the second 90 min later, after breakfast. The results showed that inter-individual sample variability was low (patients no. 
Cardiopulmonary exercise test
Each subject performed a familiarization exercise test upright on an electromagnetically-braked cycle ergometer (Ergometrics 800S). One-to-two weeks later, a cardiopulmonary exercise test was performed. Heart rate was continuously monitored and a 12-lead electrocardiogram was recorded at 1 min intervals until recovery. At these same times, blood pressure was measured manually using a brachial sphygmomanometer. After 1 min of rest and 2 min of loadless warm-up, the work rate was automatically increased by 1 W every 3 s in a ramp-like manner. Criteria for stopping exercise were fatigue, dyspnoea, ischaemic ST-T wave changes, complex ventricular arrhythmias and a reduction in systolic blood pressure of d10 mmHg with increasing work rate. A positive exercise test was defined as either typical angina and 1 mm ST segment depression (1 mm ST depression ) or more, or ST downsloping d3 mm without anginal pain. During the exercise test, subjects breathed through a mouthpiece connected to a low-resistance one-way valve. Measurements of inspiratory and expiratory volumes and flows as well as oxygen uptake and carbon dioxide production were performed breath-by-breath on a Sensormedics 2900 Z unit (Yorba Linda, California). Oxygen uptake at peak was considered as the average during the last 15 s of an exercise session. The anaerobic threshold was measured by the V-slope method [15] .
Dobutamine stress echocardiography
Patients were studied in the morning in the fasting state using a protocol recently described [16] . Briefly, twodimensional echocardiography was performed with patients in the left lateral position from standard views using a wide-angle mechanical scanner (Challenge-ESAOTE, Italy). The ECG was monitored continuously. Dobutamine was infused into a peripheral vein, following an incremental regimen of 5 g . kg 1 every 3 min to a maximum of 20 g . kg 1 . End-points were a new wall motion abnormality, significant ST segment changes (d1 mm depression or elevation in two contiguous leads), angina, supraventricular or ventricular significant arrhythmias, or completion of the protocol.
Measurements
A biplane algorithm was used to calculate left ventricular volumes. Left ventricular end-diastolic and endsystolic volumes were obtained from the apical four and two-chamber views using a modified Simpson's rule from which ejection fraction was automatically calculated as the difference between end-diastolic volume and end-systolic volume normalized to end-diastolic volume. A 16-segment model was used for analysis. Each segment was visually graded using a semiquantitative scoring system: 1=normal; 2=hypokinetic; 3=akinetic; 4=dyskinetic. A regional systolic wall thickening score index, defined as the sum of scores of each segment divided by the number of interpreted segments, was calculated at rest and at each stage of dobutamine infusion. As previously published, in our laboratory a 20% reduction in systolic wall thickening represents the 95% confidence interval discriminating a significant difference between a normal and an abnormal contractile response to low-dose dobutamine.
Data analysis
All studies were recorded on videotape and the data entered into a personal computer (Macintosh Quadra 660 AV) to obtain a simultaneous side-by-side display of rest and stress images for any individual study performed at entry and during follow-up. A response was considered normal when segments with normal wall thickening at rest had a persistent hyperdynamic response to dobutamine. A viable response was an improvement in systolic wall thickening by at least one grade in two adjacent segments with rest asynergy at any stage of dobutamine infusion. An ischaemic response was defined by the development of hypokinesia, akinesia or dyskinesia of a segment that was normal at rest, followed by a reduction of thickening at higher doses of dobutamine infusion. A biphasic response (initial improvement of thickening followed by
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deterioration at higher dobutamine doses) was also considered indicative of myocardial ischaemia. A reduction in systolic wall thickening from entry to follow-up by d1 at peak infusion or a d20% reduction in systolic wall thickening in at least two adjacent segments, or both, was interpreted as an improvement in the contractile response to dobutamine.
Myocardial scintigraphy
At the end of dobutamine stress echocardiography, 3 mCi of thallium was injected into an antecubital vein. Planar 201-thallium imaging was started within 5 min in the anterior, 45 left anterior oblique and 70 left anterior oblique views (Apex Elscint). Redistribution studies were performed 3 h after stress imaging. Twentyfour hours later, 1 mCi of thallium was reinjected in patients with scintigraphic evidence of a fixed defect noted in the redistribution images. After reinjection, a third set of images was reacquired within 15 min.
Data analysis
On entry and during follow-up, thallium images were analysed both qualitatively and quantitatively as previously described [13] . Briefly, the serial images were interpreted by visual analysis with the aid of computer quantification. The left ventricle on each view was divided into five segments (15 segments in total). Each segment was visually graded on a five-point scale: 0 (normal uptake), 1 (mild reduction), 2 (evident reduction), 3 (severe reduction) and 4 (absent uptake). We defined a thallium activity score index as the sum of thallium scores of each myocardial segment divided by the number of segments analysed. 'White on black' display using a linear gray scale was used. Segments with a score d2 on stress images were considered abnormal. Segments with an initial perfusion abnormality were considered completely reversible when the score was <2 on delayed scans and partially reversible when the score improved by one grade on delayed images. Defects with no change in thallium score between initial and delayed images were considered irreversible. Myocardial segments with irreversible defects were considered to have enhanced thallium activity after reinjection as compared to the redistribution study if the regional score decreased by one or more. A circumferential count profile analysis was also performed. Thallium images obtained in the follow-up studies were read using the same methods as used in the entry study and were compared side by side to the corresponding pre-training images. Improvement in thallium uptake in the follow-up study, as compared with the entry study, was defined as an increase in thallium activity by one or more grades in any of the three acquisition imaging series.
Coronary angiography
Coronary angiography was performed by using the Judkins' technique [17] with multiple projections (Optimus M200, Philips, The Netherlands). Coronary artery images were analysed by a computer-assisted quantitative system (Digital Cardiac Imaging, Philips). A coronary artery stenosis was considered significant if a d50% reduction in luminal diameter was detected. Coronary collateral circulation was assessed using the Rentrop's score [18] from 0 (no collaterals) to 3 (complete filling of the infarct-related artery). Angiograms at entry and at 8 weeks were compared. An increase of stenosis by d10% (score +1) was interpreted as progression of stenosis, whereas a reduction of d10% (score 1) was interpreted as regression. A pre-(entry) and post-(at 8 weeks) difference of less than 10% was considered to indicate no change (score 0).
Statistical analysis
Pre-post differences in all variables were compared among groups using the Fisher exact test. A value of P<0·05 was considered to indicate a significant difference. The correlation between changes in the variables was determined using least-squares linear regression analysis. Values were expressed as mean SD.
Results
No patients were withdrawn from the study. Patients subjected to exercise had no significant untoward events during the exercise sessions, and regularly attended the hospital gym. The average percentage of exercise sessions attended was 92% (88-100%). Two patients had mild cephalea 24-48 h after the beginning of treatment with dipyridamole.
Metabolic and haemodynamic
On initial evaluation, seven patients developed myocardial ischaemia during the exercise test (group A: 3 patients; group B: 2 patients; group C: 2 patients). As shown in Table 2 , there were no differences in any considered variables among groups.
In patients treated with dipyridamole alone and in control patients there were no significant differences between the metabolic and haemodynamic responses to cardiopulmonary exercise test at entry and the responses to the same test after 8 weeks (Table 2 ). By contrast, in patients treated with a combination of exercise training and dipyridamole, significant improvements in overall functional capacity, as indicated by peak Ṽ O 2 (22%, P=0·008) and anaerobic threshold (26%, P=0·008) were observed. Ventilation also increased significantly (24%, P=0·001), whereas the respiratory exchange ratio was unchanged, indicating that patients reached a high metabolic expenditure on exercise tests both at entry and after 8 weeks. At 8 weeks, patients of groups A and B with a positive exercise test on initial evaluation all improved their ischaemic threshold (16% and 20%, respectively). No changes in the ischaemic threshold were observed in control patients.
Dobutamine stress echocardiography
On study entry, 172 of the 307 dysfunctional myocardial segments at rest were considered viable or ischaemic in all groups (group A: 60/102; group B: 56/98; group C: 56/103). Systolic wall thickening index, left ventricular volumes and ejection fraction were similar at rest and at peak dobutamine infusion in the three groups of patients upon entry into the study (rest/peak, group A: 1·92 1·1/1·74 0·8, 175 18/168 21 ml, 118 21/ 110 18 ml, 33 4/35 3·5%; group B: 2 1·3/ 1·78 1·1, 170 21/165 24 ml, 116 18/107 15 ml, 32 4/35·5 4·5%; group C: 1·89 1·6/1·67 1·2, 180 16/171 19 ml, 121 20/110 22 ml, 33 5/ 35·6 4·5%, respectively). After 8 weeks, peak ejection fraction was significantly higher in groups receiving dipyridamole (group A: +15·4%, P<0·05; group B: +18·3%, P=0·02), due to a lower peak end-systolic volume (P<0·001 for both vs group C). A significant improvement was also observed in the peak systolic wall thickening index of both groups of patients at 8 weeks (23% and 29·5%, respectively; P=0·01 and 0·001 vs group C). Resting blood pressure was not significantly different from baseline and among groups.
At 8 weeks there was a significant improvement in the contractile response to dobutamine in 66 dysfunctional segments (group A: 14; group B: 22; group C: 2; P=0·01). In exercised patients receiving dipyridamole (group B), 33% of hypokinetic segments at baseline on study entry improved, along with 57% of akinetic segments. No changes were observed in dyskinetic segments. In patients treated with dipyridamole alone (group A) 20% of hypokinetic segments and 18% of akinetic segments improved their score (P<0·05). No improvements were observed in control patients (group C).
Myocardial scintigraphy
As shown in Table 3 , on study entry there were no significant differences in thallium uptake among groups of patients. At 8 weeks, both groups A and B had a significant increase in the number of myocardial segments with higher thallium uptake, along with an increase in the number of myocardial segments with normal thallium uptake compared to group C (P=0·02). A parallel improvement in the thallium uptake score index was also observed in these two groups (P=0·001). However, the thallium uptake score index was higher in group A than group B (group A: delta 0·38; group B: delta 0·52; P=0·02). Control patients had no significant changes.
The reproducibility of the score index was previously assessed on 55 consecutive patients with ischaemic cardiomyopathy by three independent experienced observers blinded to each other's interpretation and the clinical picture. Average scores were 2·1 0·96, 2·03 0·93 and 2·03 0·85 (P=0·72).
Plasma adenosine
Plasma adenosine levels were similar in the three groups on study entry (Table 4) . At 4 and 8 weeks, adenosine levels were significantly increased in patients of groups A and B, while no changes occurred in control patients (P=0·001). At 8 weeks, the combination of dipyridamole with exercise determined a 33% greater increase in plasma adenosine concentration than dipyridamole given alone (P<0·01).
Coronary angiography
The number of diseased coronary vessels as well as collaterals were similar in the three groups of patients at entry in the study (Table 1) . At 8 weeks, no significant changes were observed in the number and severity of pre-existing epicardial coronary artery stenoses in all 
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groups. However, as shown in Fig. 1 , the coronary collateral score significantly improved in groups A and B, while it was unchanged in group C patients (P=0·001 vs C). There was an increase in the collateral score compared to entry in all patients who were exercised and treated with dipyridamole; all but two patients who received dipyridamole alone improved their score. By contrast, at 8 weeks only one patient in group C had an increased score, while in nine patients there was no change.
The reproducibility of the collateral score was previously assessed in 55 consecutive patients with ischaemic cardiomyopathy by three independent experienced observers blinded to each other's interpretation and to the clinical picture. Average scores were 0·95 0·91, 0·93 0·91, 0·87 0·82 (P=0·46).
Correlations
At 8 weeks, significant correlations were observed between 'delta' (defined as change from entry to 8 weeks) plasma adenosine levels and either the delta thallium uptake score index (r= 0·70, P<0·001) or delta collateral score (r=0·72, P<0·001). Changes in the coronary collateral score were also inversely correlated with changes in the thallium uptake score index (r= 0·61; P=0·0003). A significant inverse relationship was also observed between the delta collateral score and the delta systolic wall thickening score index (r= 0·66; P=0·001).
Discussion
The results of the present investigation show that: (1) dipyridamole given alone for 8 weeks improved myocardial thallium uptake, coronary collateralization and left ventricular systolic performance in patients with ischaemic cardiomyopathy; (2) exercise training potentiates all these effects.
Dipyridamole, adenosine and coronary collaterals
Previous investigations on rats and rabbits have demonstrated that chronic dipyridamole treatment stimulates the growth of coronary collaterals by increasing myocardial capillary density [12, 21, 22] . New microvessels sprout directly from capillaries [23] . An increase in capillary density would potentially increase the number of sprouts, and thereby increase coronary collateralization. The effect of dipyridamole has been attributed to an elevation of the concentration of endogenous adenosine [24] . Adenosine induces vascular relaxation through the activation of A 2 adenosine receptors present in the vascular smooth muscle and presumably endothelial cells [7, 8] . Adenosine has also been implicated in a variety of processes related to angiogenesis. Specifically, adenosine can increase the number of endothelial cells [9, 10] , DNA synthesis [25] and vascularity [26] . More recently, it has been shown that bovine retinal pericytes and endothelial cells [27] , and human retinal endothelial cells [28] increase adenosine vascular endothelial growth factor synthesis. This may be because adenosine stimulates the opening and growth of coronary collateral vessels, an effect triggered and amplified by bouts of tachycardia induced by intermittent exercise. In fact, myocardial adenosine levels are increased when heart rate is increased by pacing or exercise [29] . As shown in this study, the combination of dipyridamole with exercise training determines higher levels of plasma adenosine than when dipyridamole is given alone ( Table 4 ). The higher the increase in plasma adenosine the greater the coronary collateralization.
The findings of the present study provide indirect but further evidence that adenosine contributes to myocardial angiogenesis. Thus, adenosine may increase oxygen supply to the deprived myocardium acutely by causing coronary vasodilation and chronically by promoting angiogenesis (Fig. 2) .
Myocardial perfusion
At 8 weeks after entry into the study, patients who were both exercised and received dipyridamole and patients who received dipyridamole without exercise training had significant improvements in myocardial thallium uptake and coronary collaterals as compared with controls. However, only exercised patients showed evidence of an increase in functional capacity. Dipyridamole alone improved thallium uptake by 15·8%, whereas dipyridamole in combination with exercise training increased thallium uptake by 26% (P=0·038). A similar increase in thallium uptake was recently demonstrated in a group of patients with ischaemic heart disease and depressed left ventricular systolic function after an exercise training programme of identical intensity, frequency and duration [13] . These results suggest the following considerations: (1) dipyridamole by itself is a sufficient stimulus to improve myocardial perfusion; (2) moderate exercise training potentiates the effects of dipyridamole on collateralization and perfusion of dysfunctional myocardium; (3) the increased functional capacity after exercise training is mainly related to peripheral adaptations, since the improvement in perfusion in dipyridamole-treated patients is not sufficient to increase peak Ṽ O 2 .
The improvement in myocardial perfusion was evident in collateral-dependent regions and was correlated with an increased contractile response to dobutamine of dysfunctional segments. An hypothesis may be that, in the presence of a significant coronary artery stenosis, dipyridamole determines vasodilation by increasing the concentration of adenosine in coronary vessels. As a matter of fact, adenosine-independent vasodilation [19] .
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induced by diltiazem does not increase collateraldependent perfusion [5] . If we assume that plasma levels of adenosine closely reflect adenosine concentration in coronary vessels, the increase in plasma adenosine after dipyridamole administration can play a direct role in explaining increased myocardial perfusion. Other mechanisms may be involved. Exercise, by improving endothelium-dependent relaxation of coronary arteries, can potentiate the effects of adenosine on collaterals' formation and growth. Functional adaptations of small coronary vessels to exercise, in association with a greater capillary diffusion capacity, can result in a greater myocardial perfusion and a less ischaemic dysfunction [5, 16, 19, 20] .
Limitations
Some methodological limitations can arise from the use of a planar technique for detecting changes in myocardial perfusion. However, planar imaging has been previously validated in other laboratories that used positron emission tomography to detect viable/ ischaemic myocardium [30] . The measurements of adenosine concentration in the venous blood should be considered as estimates because of technical difficulties deriving from the very short half life of this nucleoside. However, the method gave reproducible results. It is possible that dipyridamole might affect resting perfusion by dilating preexisting collaterals. This hypothesis could have been excluded if thallium defects remained unchanged 24 h after initiating oral dipyridamole. Myocardial adenosine concentration has not been directly measured. The increased plasma levels of adenosine in patients receiving dipyridamole do not necessarily reflect the level of adenosine in the myocardium. However, patients treated with dipyridamole had the highest improvement in thallium uptake in the collateraldependent myocardium.
Conclusion
Dipyridamole treatment caused an elevation of plasma adenosine concentration that was associated with improvements of myocardial perfusion and coronary collateralization. The combination of exercise with dipyridamole caused greater improvements of myocardial perfusion and collateralization than dipyridamole alone. However, dipyridamole may prove beneficial in patients that cannot tolerate exercise. These preliminary results can provide novel working hypothesis and potential clinical implications in patients with ischaemic heart disease.
